The Department of Defense, through the Defense Health Agency (DHA), intends to enter into a sole source acquisition with Premier Shockwave for the provision of OssaTron® medical devices, which utilize Extracorporeal Shock Wave Treatment (ESWT) to treat chronic musculoskeletal conditions. This procurement aims to establish a master blanket purchase agreement (BPA) with Premier Shockwave, the sole owner of the OssaTron® devices, to ensure the availability of these specialized medical apparatuses for addressing specific health needs. The devices are critical in the medical field for managing chronic pain and enhancing patient recovery. Interested parties can reach out to Malcolm Dodson at malcolm.dodson.ctr@health.mil or by phone at 703-275-6322, or Edgar DuChemin at edgar.r.duchemin.civ@health.mil or 703-275-6348 for further information.